EU to okay deal with CureVac for supply of up to 405 million Covid vaccines
The European Commission will authorise on Tuesday a deal with biotech firm CureVac to secure up to 405 million doses of its potential Covid-19 vaccine, the head of the European Commission Ursula von der Leyen said on Monday.
The Commission president also said she hopes to finalise a deal soon with Moderna for its Covid-19 vaccine.